Trending News

Changes to Civil Rights Enforcement: New Executive Order Eliminates Disparate-Impact Liability in Federal Regulations

How Are Family Offices Building Smarter Wealth? Structural Alpha (11 Examples)

DOJ Rule Restricting Sensitive Data Transfers Takes Effect

The Trump Administration’s Diversity, Equity, and Inclusion (DEI) Executive Orders: A Brief Primer

Trump Administration Announces "Reciprocal" Tariffs

What Every Multinational Company Should Know About … The Global and Reciprocal Tariffs Announcement

Blockading the Ports: U.S. Imposes 10% Global Tariff; Higher Reciprocal Tariff Rates by Country

Fifth Circuit Court of Appeals Negates Ruling on Federal Contractor Minimum Wage

New Executive Order Rescinds the $17.75 Per Hour Federal Contractor Minimum Wage

Medicare Telehealth Gets Another Temporary Lifeline – Will Congress Make it Permanent?

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Posted On Friday, February 21, 2025
Fortrea to Add Erin L. Russell to Board of Directors
Posted On Friday, February 21, 2025
Tevogen Bio’s First Trading Year Efficiency: 600% Higher Market Cap Per Team Member, 79% Insider-Owned
Posted On Friday, February 21, 2025
Dogecoin Cash, Inc. (OTC:CBDS) Announces Strategic Expansion of Crypto Holdings with Acquisition of 420 Million Dogecoin Cash ($DOG)
Posted On Friday, February 21, 2025
Ensho Therapeutics Announces Presentation of Data Highlighting NSHO-101 as a Once-Daily Oral Agent for the Potential Treatment of Inflammatory Bowel Disease at ECCO 2025
Posted On Friday, February 21, 2025
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
Posted On Friday, February 21, 2025
Longeveron® to Report Full Year 2024 Financial Results and Host Conference Call on February 28, 2025
Posted On Friday, February 21, 2025
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
Posted On Friday, February 21, 2025
Inozyme Pharma to Present Recently Announced Interim Data for INZ-701 in Infants and Young Children with ENPP1 Deficiency at CHOP Cardiology 2025
Posted On Friday, February 21, 2025
NKGen Biotech Announces Administration of First Dose of Troculeucel to Frontotemporal Dementia Patient Under FDA-Cleared Compassionate Use Program
Posted On Friday, February 21, 2025
Madrigal Pharmaceuticals to Participate in the 45th Annual TD Cowen Health Care Conference
Posted On Friday, February 21, 2025
Tiziana Life Sciences Announces Agreement for Product Development Services with Renaissance Lakewood, LLC
Posted On Friday, February 21, 2025
Ocugen to Host Conference Call on Wednesday, March 5, 2025 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2024 Financial Results
Posted On Friday, February 21, 2025
Nusano Named “Researcher of the Year” at Inaugural Best of BioHive Awards
Posted On Friday, February 21, 2025
Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.
Posted On Friday, February 21, 2025
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
Posted On Friday, February 21, 2025
Yaqrit strengthens board and senior management ahead of multi-prong clinical push in advanced liver disease
Posted On Friday, February 21, 2025
ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients
Posted On Thursday, February 20, 2025
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
Posted On Thursday, February 20, 2025
BioAge Labs to Participate in TD Cowen's 45th Annual Health Care Conference
Posted On Thursday, February 20, 2025
Phoenix Molecular Designs Dosed First Patient in Dauntless-1, a Phase 2 Clinical Trial of PMD-026 in Combination with Fulvestrant for RSK2-high Breast Cancer
Posted On Thursday, February 20, 2025
Cardiff Oncology to Report Fourth Quarter 2024 Results and Provide Business Update
Posted On Thursday, February 20, 2025
Artiva Biotherapeutics to Participate in the TD Cowen 45th Annual Health Care Conference
Posted On Thursday, February 20, 2025
Y-mAbs to Announce Fourth Quarter and Full Year 2024 Financial and Operating Results on March 4, 2025
Posted On Thursday, February 20, 2025
Terns Pharmaceuticals Appoints Robert Azelby to Board of Directors
Posted On Thursday, February 20, 2025

Print